Kaiser Permanente

Vallejo, California 94589-2441

4 studies enrolling now · 11 studies all time

What they study most

Breast Cancer, Breast Neoplasms, Fallopian Tube Neoplasms, Hemophilia A, Locally Recurrent Breast Cancer, Metastatic Breast Cancer, Metastatic Pancreatic Cancer, Neoplasm Metastasis, Non-Small Cell Lung Cancer, Ovarian Neoplasms, Pancreatic Cancer, Peritoneal Neoplasms

Studies at this site

• A Three-Part Phase 3 Study of Sofetabart Mipitecan in Participants With Platinum-Resistant (Part A) and Platinum-Sensitive (Parts B and C) Ovarian Cancer — Recruiting now
• A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA) — Recruiting now
• A Gene Therapy Study of SPK-8011QQ in Adults With Severe or Moderately Severe Hemophilia A — Recruiting now
• Clinical Study of Ivonescimab for First-line Treatment of Metastatic NSCLC Patients — Recruiting now
• Study to Assess Safety and Efficacy of Atezolizumab (MPDL3280A) Compared to Best Supportive Care Following Chemotherapy in Patients With Lung Cancer [IMpower010] — Running, not enrolling
• Endocrine Therapy With or Without Abemaciclib (LY2835219) Following Surgery in Participants With Breast Cancer — Running, not enrolling
• A Study of Pertuzumab in Addition to Chemotherapy and Trastuzumab as Adjuvant Therapy in Participants With Human Epidermal Growth Receptor 2 (HER2)-Positive Primary Breast Cancer — Completed
• The BEACON Study (Breast Cancer Outcomes With NKTR-102) — Completed
• A Study Evaluating IPI-926 in Combination With Gemcitabine in Patients With Metastatic Pancreatic Cancer — Completed
• An Efficacy Study of MORAb-009 in Subjects With Pancreatic Cancer — Completed
• Phase II Trial of Abraxane in Front Line Therapy of Hormone Refractory Metastatic Prostate Cancer — Completed